Annual CFI
$13.24 M
+$8.37 M+171.52%
December 31, 2023
Summary
- As of February 7, 2025, MTNB annual cash flow from investing activities is $13.24 million, with the most recent change of +$8.37 million (+171.52%) on December 31, 2023.
- During the last 3 years, MTNB annual CFI has risen by +$53.91 million (+132.56%).
- MTNB annual CFI is now -21.04% below its all-time high of $16.77 million, reached on December 31, 2021.
Performance
MTNB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$9.65 M
+$12.58 M+428.32%
September 30, 2024
Summary
- As of February 7, 2025, MTNB quarterly cash flow from investing activities is $9.65 million, with the most recent change of +$12.58 million (+428.32%) on September 30, 2024.
- Over the past year, MTNB quarterly CFI has increased by +$8.56 million (+789.85%).
- MTNB quarterly CFI is now at all-time high.
Performance
MTNB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$11.67 M
+$8.56 M+275.66%
September 30, 2024
Summary
- As of February 7, 2025, MTNB TTM cash flow from investing activities is $11.67 million, with the most recent change of +$8.56 million (+275.66%) on September 30, 2024.
- Over the past year, MTNB TTM CFI has increased by +$1.43 million (+13.95%).
- MTNB TTM CFI is now -54.78% below its all-time high of $25.80 million, reached on September 30, 2021.
Performance
MTNB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MTNB Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +171.5% | +789.9% | +13.9% |
| 3 y3 years | +132.6% | +789.9% | +13.9% |
| 5 y5 years | +2571.0% | +789.9% | +13.9% |
MTNB Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.0% | +171.5% | at high | +354.4% | -30.4% | +2294.9% |
| 5 y | 5-year | -21.0% | +132.6% | at high | +117.5% | -54.8% | +119.1% |
| alltime | all time | -21.0% | +132.6% | at high | +117.5% | -54.8% | +119.1% |
Matinas BioPharma Holdings Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $9.65 M(-428.3%) | $11.67 M(+275.7%) |
| Jun 2024 | - | -$2.94 M(-246.9%) | $3.11 M(-74.6%) |
| Mar 2024 | - | $2.00 M(-32.4%) | $12.24 M(-7.6%) |
| Dec 2023 | $13.24 M(+171.5%) | $2.96 M(+173.1%) | $13.24 M(+29.3%) |
| Sep 2023 | - | $1.08 M(-82.5%) | $10.24 M(-31.3%) |
| Jun 2023 | - | $6.20 M(+106.6%) | $14.91 M(+203.2%) |
| Mar 2023 | - | $3.00 M(-7242.9%) | $4.92 M(+0.8%) |
| Dec 2022 | $4.88 M(-70.9%) | -$42.00 K(-100.7%) | $4.88 M(-2.0%) |
| Sep 2022 | - | $5.75 M(-251.6%) | $4.98 M(-1036.0%) |
| Jun 2022 | - | -$3.79 M(-228.1%) | -$531.60 K(-104.9%) |
| Mar 2022 | - | $2.96 M(+5122.2%) | $10.91 M(-34.9%) |
| Dec 2021 | $16.77 M(-141.2%) | $56.70 K(-76.6%) | $16.77 M(-35.0%) |
| Sep 2021 | - | $242.70 K(-96.8%) | $25.80 M(+13.3%) |
| Jun 2021 | - | $7.65 M(-13.2%) | $22.78 M(-1.5%) |
| Mar 2021 | - | $8.82 M(-3.0%) | $23.12 M(-156.8%) |
| Dec 2020 | -$40.67 M(+576.5%) | $9.09 M(-426.9%) | -$40.67 M(-26.5%) |
| Sep 2020 | - | -$2.78 M(-134.8%) | -$55.36 M(+5.1%) |
| Jun 2020 | - | $7.99 M(-114.5%) | -$52.66 M(-13.6%) |
| Mar 2020 | - | -$54.97 M(+880.6%) | -$60.96 M(+914.2%) |
| Dec 2019 | -$6.01 M(+1021.7%) | -$5.61 M(+7537.2%) | -$6.01 M(+1382.4%) |
| Sep 2019 | - | -$73.40 K(-76.9%) | -$405.50 K(-33.2%) |
| Jun 2019 | - | -$317.90 K(+2138.7%) | -$607.40 K(+35.5%) |
| Mar 2019 | - | -$14.20 K(<-9900.0%) | -$448.20 K(-16.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$535.90 K(-43.1%) | $0.00(-100.0%) | -$535.90 K(-18.1%) |
| Sep 2018 | - | -$275.30 K(+73.5%) | -$654.20 K(+58.4%) |
| Jun 2018 | - | -$158.70 K(+55.7%) | -$413.10 K(-60.4%) |
| Mar 2018 | - | -$101.90 K(-13.9%) | -$1.04 M(+10.8%) |
| Dec 2017 | -$942.20 K(<-9900.0%) | -$118.30 K(+245.9%) | -$942.20 K(+14.4%) |
| Sep 2017 | - | -$34.20 K(-95.7%) | -$823.90 K(+4.3%) |
| Jun 2017 | - | -$789.70 K(<-9900.0%) | -$789.70 K(<-9900.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2016 | - | $0.00(0.0%) | -$22.90 K(-38.8%) |
| Jun 2016 | - | $0.00(-100.0%) | -$37.40 K(+592.6%) |
| Dec 2015 | -$5400.00(-98.1%) | -$22.90 K(+57.9%) | -$5400.00(-130.9%) |
| Sep 2015 | - | -$14.50 K(-57.2%) | $17.50 K(+1246.2%) |
| Jun 2015 | - | -$33.90 K(-151.4%) | $1300.00(-104.4%) |
| Mar 2015 | - | $65.90 K(>+9900.0%) | -$29.30 K(-89.8%) |
| Dec 2014 | -$288.50 K(+206.3%) | $0.00(-100.0%) | -$288.50 K(-18.6%) |
| Sep 2014 | - | -$30.70 K(-52.4%) | -$354.40 K(+0.7%) |
| Jun 2014 | - | -$64.50 K(-66.6%) | -$352.00 K(+22.4%) |
| Mar 2014 | - | -$193.30 K(+193.3%) | -$287.50 K(+205.2%) |
| Dec 2013 | -$94.20 K | -$65.90 K(+132.9%) | -$94.20 K(+232.9%) |
| Sep 2013 | - | -$28.30 K(<-9900.0%) | -$28.30 K(<-9900.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
FAQ
- What is Matinas BioPharma Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual CFI year-on-year change?
- What is Matinas BioPharma Holdings quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly CFI year-on-year change?
- What is Matinas BioPharma Holdings TTM cash flow from investing activities?
- What is the all time high TTM CFI for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings TTM CFI year-on-year change?
What is Matinas BioPharma Holdings annual cash flow from investing activities?
The current annual CFI of MTNB is $13.24 M
What is the all time high annual CFI for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual cash flow from investing activities is $16.77 M
What is Matinas BioPharma Holdings annual CFI year-on-year change?
Over the past year, MTNB annual cash flow from investing activities has changed by +$8.37 M (+171.52%)
What is Matinas BioPharma Holdings quarterly cash flow from investing activities?
The current quarterly CFI of MTNB is $9.65 M
What is the all time high quarterly CFI for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly cash flow from investing activities is $9.65 M
What is Matinas BioPharma Holdings quarterly CFI year-on-year change?
Over the past year, MTNB quarterly cash flow from investing activities has changed by +$8.56 M (+789.85%)
What is Matinas BioPharma Holdings TTM cash flow from investing activities?
The current TTM CFI of MTNB is $11.67 M
What is the all time high TTM CFI for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high TTM cash flow from investing activities is $25.80 M
What is Matinas BioPharma Holdings TTM CFI year-on-year change?
Over the past year, MTNB TTM cash flow from investing activities has changed by +$1.43 M (+13.95%)